BOSTON — The United States Judicial Panel on Multidistrict Litigation (U.S. JPML) recently granted a motion to consolidate several Zofran lawsuits which had similar claims.
These lawsuits will be consolidated in Massachusetts district court and have a number of components in common including that they have all been brought against GlaxoSmithKline (GSK), the manufacturer of the anti-nausea drug Zofran, and they all allege that the plaintiff suffered injuries as the result of taking Zofran for off-label use as a treatment for morning sickness during pregnancy.
About 60 lawsuits were affected by this order to consolidate.
Zofran Side Effects
Zofran (also known as ondansetron) was first approved by the United States Food and Drug Administration in 1991 – but only for use in treating nausea in cancer patients undergoing radiation therapy or chemotherapy and in other patients who had just undergone surgery. For several years, however, doctors have been prescribing Zofran as a solution for pregnant women who have been experiencing hyperemesis gravidarum, or extreme morning sickness.
Unfortunately, several studies – done all over the globe – have shown a strong correlation between the use of ondansetron while pregnant with the development of birth defects in the women’s babies. One study done in the United States demonstrated a higher risk for babies developing cleft palate if their mothers took Zofran while pregnant with them. Two separate European studies (one done in Denmark and the other in Sweden) showed an increased risk of heart complications for the babies, and an Australian study indicated a link between Zofran use and kidney complications for the children. In addition to alleging the injuries that the studies warn of, plaintiffs have also brought lawsuits against GSK alleging that using the drug while pregnant caused other oral deformities for their children and even miscarriages and post-partum death due to the severity of the birth defects.
Effects of the Lawsuit Consolidation on Plaintiffs
The Zofran lawsuits being consolidated is largely good news for the majority of plaintiffs who have already filed a lawsuit against GSK as well as those who are thinking about it. This consolidation of these lawsuits should increase efficiencies for all plaintiffs and injured parties who are considering filing a lawsuit because the consolidation will reduce the need for both sides to spend extra money on duplicative discovery or court time. The consolidation will also prevent several different courts in several different jurisdictions from returning different or even conflicting rulings.
Our Zofran Lawyers Can Help You
Our Zofran lawsuit attorneys can help if your child was harmed by this dangerous drug. Lawsuits will be filed against the drug maker for injuries caused by to babies. You and your child may be entitled to a settlement. We do not charge any legal fees unless you receive a settlement and we pay all of the case costs. If your claim is not successful for any reason, you do not owe us anything. We put it in all in writing for you. Our Zofran lawyers will help you file your lawsuit.
Our No Fee Promise on Zofran Cases
You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:
- No money to get started
- We pay all case costs and expenses
- No legal fees whatsoever unless you receive a settlement
- Phone calls are always free.
Start Your Zofran Lawsuit
Our Zofran lawyers will help you file your lawsuit. To get started, you can:
- Submit the Free Case Review Box on this page, or
- Call (866) 280-4722 any time of day to tell us about your case.
We will listen to your story and answer your questions. If you have claim, we will start immediately.
WARNING: There are strict time deadlines for filing Zofran lawsuit claims.